During the past decade, Universität Zürich conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universität Zürich" #1 collaborator was "Eisai Europe Ltd. (United Kingdom)" with 1 trials as a collaborator and "University of Zurich" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Universität Zürich" are "Ulcerative Colitis" (3 trials), "Adjustment Disorders" (1 trials), "Aortic Stenosis" (1 trials), "Aortic Valve Disease" (1 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "Universität Zürich" in a lesser frequency.

Most popular intervention types in "Universität Zürich" are "Drug" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ontamalimab" (2 trials), "Placebo" (2 trials), "25 mg Ontamalimab" (1 trials), "75 mg Ontamalimab" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universität Zürich" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Universität Zürich". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Universität Zürich, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Universität Zürich, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Universität Zürich has several departments that took part in Clinical trials: "Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich" - 13 trials, "University Children's Hospital" - 98 trials, "Psychiatric University Clinics, Department of Child and Adolescent Psychiatry" - 5 trials, "University of Zurich, Center of Dental Medicine" - 4 trials, "Clinic of Reconstructive Dentistry" - 4 trials, "Department of Psychology, University of Zürich" - 4 trials, "MR-Center, University Children's Hospital" - 3 trials, "University Children's Hospital Zurich, Rehabilitation Centre Affoltern am Albis" - 4 trials, "Dept. of Geriatrics and Aging Research, University of Zurich / Geriatric Clinic University Hospital Zurich" - 3 trials, "Institute for Medical Microbiology, University Hospital Zurich" - 2 trials, "University of Zurich, Institute of Pharmacology and Toxicology" - 2 trials, "Clinic of General, Special care, and Geriatric Dentistry, Center of Dental Medicine, University of Zurich" - 2 trials